Jenny S Choy1, Shuang Leng2, Gabriel Acevedo-Bolton3, Semion Shaul3, Lijuan Fu1, Xiaomei Guo1, Liang Zhong4, Julius M Guccione3, Ghassan S Kassab5. 1. California Medical Innovations Institute, Inc., San Diego, CA, USA. 2. National Heart Centre Singapore, Singapore, Singapore. 3. Department of Surgery, University of California at San Francisco, San Francisco, CA, USA. 4. National Heart Centre Singapore, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore. 5. California Medical Innovations Institute, Inc., San Diego, CA, USA. Electronic address: gkassab@calmi2.org.
Abstract
BACKGROUND: Progressive thinning and dilation of the LV due to ischemic heart failure (IHF) increases wall stress and myocardial oxygen consumption. Injectable biopolymers implanted in the myocardial wall have been used to increase wall thickness to reduce chamber volume, decrease wall stress, and improve cardiac function. We sought to evaluate the efficacy of a biopolymer (Algisyl-LVR) to prevent left ventricular (LV) remodeling in a swine model of IHF. METHODS: IHF was induced in 11 swine by occluding the marginal obtuse branches of the left circumflex artery. Eight weeks later, Algisyl-LVR was injected into the LV myocardial free wall in five of the 11 animals. Echocardiographic examinations were done every 2weeks for 16weeks. RESULTS: Within eight weeks of treatment, the ejection fraction increased from 30.5%±7.7% to 42.4%±3.5% (treated group) vs. 37.3%±3.8% to 34.3%±2.9% (control), p<0.01. Stroke volume increased from 18.5±9.3mL to 41.3±13.3mL (treated group) vs. 25.4±2.3mL to 31.4±5.3mL (control), p<0.05. Wall thickness in end-diastole of the infarcted region changed from 0.69±0.06cm to 0.81±0.13cm (treated group) vs. 0.73±0.09cm to 0.68±0.11cm (control), p<0.05. Sphericity index remained almost unchanged after treatment, although differences were found at the end of the study between both groups (p<0.001). Average myofiber stress changed from 16.3±5.8kPa to 10.2±4.0kPa (treated group) vs. 15.2±4.8kPa to 17.9±5.6kPa (control), p<0.05. CONCLUSIONS: Algisyl-LVR is an effective strategy that serves as a micro-LV assist device to reduce stress and hence prevent or reverse maladaptive cardiac remodeling caused by IHF in swine.
BACKGROUND: Progressive thinning and dilation of the LV due to ischemic heart failure (IHF) increases wall stress and myocardial oxygen consumption. Injectable biopolymers implanted in the myocardial wall have been used to increase wall thickness to reduce chamber volume, decrease wall stress, and improve cardiac function. We sought to evaluate the efficacy of a biopolymer (Algisyl-LVR) to prevent left ventricular (LV) remodeling in a swine model of IHF. METHODS:IHF was induced in 11 swine by occluding the marginal obtuse branches of the left circumflex artery. Eight weeks later, Algisyl-LVR was injected into the LV myocardial free wall in five of the 11 animals. Echocardiographic examinations were done every 2weeks for 16weeks. RESULTS: Within eight weeks of treatment, the ejection fraction increased from 30.5%±7.7% to 42.4%±3.5% (treated group) vs. 37.3%±3.8% to 34.3%±2.9% (control), p<0.01. Stroke volume increased from 18.5±9.3mL to 41.3±13.3mL (treated group) vs. 25.4±2.3mL to 31.4±5.3mL (control), p<0.05. Wall thickness in end-diastole of the infarcted region changed from 0.69±0.06cm to 0.81±0.13cm (treated group) vs. 0.73±0.09cm to 0.68±0.11cm (control), p<0.05. Sphericity index remained almost unchanged after treatment, although differences were found at the end of the study between both groups (p<0.001). Average myofiber stress changed from 16.3±5.8kPa to 10.2±4.0kPa (treated group) vs. 15.2±4.8kPa to 17.9±5.6kPa (control), p<0.05. CONCLUSIONS:Algisyl-LVR is an effective strategy that serves as a micro-LV assist device to reduce stress and hence prevent or reverse maladaptive cardiac remodeling caused by IHF in swine.
Authors: Samuel T Wall; Joseph C Walker; Kevin E Healy; Mark B Ratcliffe; Julius M Guccione Journal: Circulation Date: 2006-11-27 Impact factor: 29.690
Authors: Kevin L Sack; Eric Aliotta; Jenny S Choy; Daniel B Ennis; Neil H Davies; Thomas Franz; Ghassan S Kassab; Julius M Guccione Journal: Acta Biomater Date: 2020-05-16 Impact factor: 8.947
Authors: David S Li; Reza Avazmohammadi; Christopher B Rodell; Edward W Hsu; Jason A Burdick; Joseph H Gorman; Robert C Gorman; Michael S Sacks Journal: Acta Biomater Date: 2020-07-30 Impact factor: 8.947
Authors: Yaghoub Dabiri; Alex Van der Velden; Kevin L Sack; Jenny S Choy; Julius M Guccione; Ghassan S Kassab Journal: Sci Rep Date: 2020-12-18 Impact factor: 4.379
Authors: Kevin L Sack; Eric Aliotta; Daniel B Ennis; Jenny S Choy; Ghassan S Kassab; Julius M Guccione; Thomas Franz Journal: Front Physiol Date: 2018-05-29 Impact factor: 4.566